Doctors Can Now Detect Hard-to-Diagnose Prostate Cancer, Weill Cornell Medical College Study

8/9/2012 7:59:44 AM

Researchers have successfully developed and tested a new prostate cancer screening method that uses the combined power of a novel drug therapy and changes in PSA levels over time to identify men with a high PSA who are more likely to have aggressive prostate cancer despite negative biopsies. The new study by researchers at NewYork-Presbyterian Hospital/Weill Cornell Medical Center, published in the Journal of Urology, shows that PSA can be a much more effective marker for prostate cancer when an additional drug therapy is used than it can as a stand-alone test, which is how it is currently used by physicians.

Read at EurekAlert!

Read at MedicalXpress

Read at News Release

Read Article at

Related Companies

News Categories

• EurekAlert!

• MedicalXpress

• News Release

• Weill Cornell Medical College

• Diagnostics

• Medical Dev. & Diag. - Research